FBI LOGO TM.png
Human Insulin Market Size 2021 | Is Anticipated to Reach USD 27.71 Billion and Exhibit a CAGR of 3.4% by 2026
April 26, 2021 07:31 ET | Fortune Business Insights
Pune, India, April 26, 2021 (GLOBE NEWSWIRE) -- The global human insulin market size is anticipated to reach USD 27.71 billion by 2026. International Diabetes Federation (IDF) reported that around...
ReportLinker logo.jpg
North America Game Camera Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Type, Application
April 26, 2021 07:30 ET | ReportLinker
New York, April 26, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "North America Game Camera Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Type,...
BBDLOGO.jpg
Bombardier to Report First Quarter 2021 Financial Results and Hold Virtual Annual Meeting of Shareholders on Thursday, May 6, 2021
April 26, 2021 07:30 ET | Bombardier Inc.
MONTREAL, April 26, 2021 (GLOBE NEWSWIRE) -- Bombardier (TSX: BBD.B) will publish its financial results for the first quarter of 2021 on May 6, 2021. On the same day, Bombardier will hold its Annual...
Zai Lab logo .png
Zai Lab to Announce First Quarter 2021 Financial Results on May 10, 2021
April 26, 2021 07:30 ET | Zai Lab Limited
SHANGHAI and SAN FRANCISCO, April 26, 2021 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovative commercial-stage biopharmaceutical company, today announced that it will...
Avicanna.png
Avicanna Provides Bi-Weekly Update On Status Of Management Cease Trade Order
April 26, 2021 07:30 ET | Avicanna Inc.
/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES...
ContraFect_LOGO_Web.jpg
ContraFect Invited to Participate in the Cystic Fibrosis Target Product Profile Virtual Symposium
April 26, 2021 07:30 ET | ContraFect Corporation
YONKERS, N.Y., April 26, 2021 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX), a late clinical-stage biotechnology company focused on the discovery and development of direct lytic agents...
Mydecine.png
Mydecine to Report Full Year 2020 Financial Results on May 3, 2021
April 26, 2021 07:30 ET | Mydecine Innovations Group Inc.
DENVER, April 26, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company’), an emerging biopharma and life sciences company committed to...
InMed Pharmaceuticals Inc..jpg
InMed Pharmaceuticals Achieves 2g/L Cannabinoid Yield with IntegraSyn™
April 26, 2021 07:30 ET | InMed Pharmaceuticals Inc.
VANCOUVER, British Columbia, April 26, 2021 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM; TSX:IN), a clinical-stage company developing cannabinoid-based...
TGTX 2021 Logo
TG Therapeutics to Participate in the B. Riley Securities Neuroscience Conference
April 26, 2021 07:30 ET | TG Therapeutics, Inc.
NEW YORK, April 26, 2021 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that Michael S. Weiss, the Company’s Executive Chairman and Chief Executive Officer, will...
neph.jpg
Nephros Announces First Quarter 2021 Financial Results Conference Call
April 26, 2021 07:30 ET | Nephros, Inc.
SOUTH ORANGE, NJ, April 26, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company, today announced that it will file its first quarter...